Skip to content

51 – In-Depth Analysis of FDA cGCP Regulations (S21E2)

June 2, 2025 · 28 min

Show notes

This episode dives into the complex world of U.S. regulations for clinical trials. Examine the detailed provisions within U.S. regulations for clinical trials as we explain how FDA guidance documents, relevant sections of 21 CFR, and associated Q&A documents shape current clinical practices. We will also break down enforcement strategies, such as inspection protocols, providing practical examples of regulatory interpretations to ensure adherence to cGCP requirements.

We'll discuss how the Bioresearch Monitoring Program (BiMo) oversees clinical trials through inspections and audits. This includes GCP inspections linked to NDA's and BLA's, good laboratory practice, bio equivalence studies, and the institutional review board. The listener will also come away with an understanding of those critical to quality factors. This allows the FDA to concentrate on key areas, when triggered, rather than the entire process.

All episodes of From Concept to Medicine – A Comprehensive Drug Development Journey

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.